NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- The National Kidney Foundation has Updated Two of its Home Dialysis Resources Posted 03-13-2025
- See How Outset Medical is Bringing Home HD into Skilled Nursing Facilities Posted 03-13-2025
- Monogram Health Held a Home Dialysis Summit for its Clinicians Posted 03-13-2025
- Annual Dialysis Conference 2025 is in Las Vegas from 3/13-16/2025 Posted 03-13-2025